Company news
OncoSil Medical Ltd news in 2020
OncoSil Medical Ltd's news releases, calls and decks from 2020, newest first.
Termination of Mr Daniel Kenny as Chief Executive Officer
December 1, 2020
OncoSil receives Swiss regulatory approval
November 4, 2020
OncoSil achieves first commercial sale
October 21, 2020
Positive PanCO trial update on resected cohort
October 19, 2020
Receipt of $2.8m R&D Tax Incentive Refund
September 22, 2020
Investor Update
August 28, 2020
OncoSil receives Malaysian regulatory approval
August 27, 2020
Preliminary Final Report - Appendix 4E Announcement
August 19, 2020
HDE filing submitted in US for Bile Duct Cancer treatment
July 27, 2020
OncoSil presents clinical data at ESMO World Congress
July 3, 2020
OncoSil files for TGA registration
July 1, 2020
OncoSil receives Singapore regulatory approval
May 31, 2020
Allotment of Securities under Institutional Placement
May 7, 2020
Proposed issue of Securities - OSL
May 3, 2020
Oncosil breakthrough device receives CE Marking approval
March 31, 2020
Clarification Statement
March 27, 2020
Pause in Trading
March 26, 2020
FDA Grants Breakthrough Device Designation
March 17, 2020
Decks in 2020
- Shareholder Meeting (October 2020)
Shareholder meeting · 11 slides · Oct 20, 2020
- Investor Presentation (May 2020)
Investor deck · 37 slides · May 4, 2020